Glorikian Publications MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market Read More The MoneyBall solution to the healthcare crisis Read More What’s the key to efficient IVD development? Read More Theranos and it’s failure: What we can learn from it regarding IVDS Read More Pre-design research is essential for the IVD industry Read More IVDs and data requirements in a value-based reimbursement landscape Read More How can the in vitro diagnostics industry tap the growth potential of integrated delivery networks? Read More Do You Have the Data to Benefit from a Post-Keytruda Approval Market? Read More MDBR Interviews Harry Glorikian About the Growing Significance of In Vitro Diagnostics Read More Q&A: Healthcare Industry Expert Harry Glorikian Discusses His New IVD Manual Read More Remote Patient Care: The Future Of Remote Monitoring And Diagnostics Read More Harry Glorikian discusses the field of In Vitro diagnostics Industry Today Read More Commercializing Novel IVDs: A Comprehensive Manual for Success Read More Leadership Series Featuring Harry Glorikian, Senior Executive, Board Director, Consultant, and Investor Read More Gene Editing Will Change Everything – Just Not All At One Time Read More Early Detection: The Real Way to Beat Cancer Read More Personalized Medicine: New Opportunity in the Age of Cost-Conscious Medicine Read More Genomics: gearing up for the laboratory of the future Read More Sequencing Trends Worth Watching Read More POCT key to widespread access to healthcare Read More Prev 1 2 3 Next
How can the in vitro diagnostics industry tap the growth potential of integrated delivery networks? Read More
Leadership Series Featuring Harry Glorikian, Senior Executive, Board Director, Consultant, and Investor Read More
